Document is current
Any future updates will be listed below
-
Authors
Sze, Ying Hon https://orcid.org/0000-0002-2724-8968
Tse, Dennis Yan Yin https://orcid.org/0000-0001-7561-9121
Zuo, Bing
Li, King Kit
Zhao, Qian https://orcid.org/0000-0003-2244-6516
Jiang, Xiaoyan
Kurihara, Toshihide https://orcid.org/0000-0002-5457-2720
Tsubota, Kazuo https://orcid.org/0000-0002-8874-7111
Lam, Thomas Cheun https://orcid.org/0000-0002-3511-5620
- License Information
-
More Information
Article History
Received: 5 January 2024
Accepted: 2 October 2024
First Online: 10 October 2024
Competing interests
: Outside the submitted work, Kazuo Tsubota reports his position as CEO of Tsubota Laboratory, Inc., a company developing myopia-related treatments. Patents have been granted for the animal myopia model (JP 6637217 in Japan and CN 110392579 B in China) and applied for internationally (WO 2018/164113 A1).
